Insitu Biologics
Minnesota City
About Insitu Biologics
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments using its Matrix BioHydrogel. The company's platform develops and manufactures implantable time release products composed of its proprietary tunable and bio-polymeric hydro-gel by using hard particulates in soft matrix, enabling patients to get relieve from peri-operative regional pain by a long-lasting and long-acting non-opiate painkiller.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.9M
- Last round: Series Unknown (Dec 2025)
- Website: insitubiologics.com
- Phone: 651-337-4799
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/insitu-biologics-25667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.